Signaturefd, LLC Neogenomics Inc Transaction History
Signaturefd, LLC
- $5.21 Billion
- Q4 2024
A detailed history of Signaturefd, LLC transactions in Neogenomics Inc stock. As of the latest transaction made, Signaturefd, LLC holds 134 shares of NEO stock, worth $1,287. This represents 0.0% of its overall portfolio holdings.
Number of Shares
134
Previous 134
-0.0%
Holding current value
$1,287
Previous $1,000
100.0%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding NEO
# of Institutions
282Shares Held
124MCall Options Held
751KPut Options Held
107K-
Black Rock Inc. New York, NY19.7MShares$189 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA14.2MShares$137 Million0.0% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD6.53MShares$62.7 Million0.07% of portfolio
-
Janus Henderson Group PLC London, X06.17MShares$59.2 Million0.05% of portfolio
-
Brown Advisory Inc6.16MShares$59.2 Million0.13% of portfolio
About NEOGENOMICS INC
- Ticker NEO
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 125,796,000
- Market Cap $1.21B
- Description
- NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...